BE1022357A9 - Cassette à double fonction - Google Patents
Cassette à double fonction Download PDFInfo
- Publication number
- BE1022357A9 BE1022357A9 BE20145062A BE201405062A BE1022357A9 BE 1022357 A9 BE1022357 A9 BE 1022357A9 BE 20145062 A BE20145062 A BE 20145062A BE 201405062 A BE201405062 A BE 201405062A BE 1022357 A9 BE1022357 A9 BE 1022357A9
- Authority
- BE
- Belgium
- Prior art keywords
- spe
- column
- cassette
- cassette according
- columns
- Prior art date
Links
- 230000009977 dual effect Effects 0.000 title description 3
- 238000002414 normal-phase solid-phase extraction Methods 0.000 claims description 82
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 53
- 238000000034 method Methods 0.000 claims description 47
- HNIHOFVDKWEICB-UHFFFAOYSA-N 1-fluorocyclobutane-1-carboxylic acid Chemical compound OC(=O)C1(F)CCC1 HNIHOFVDKWEICB-UHFFFAOYSA-N 0.000 claims description 44
- 238000006243 chemical reaction Methods 0.000 claims description 44
- 150000001875 compounds Chemical class 0.000 claims description 44
- 239000003153 chemical reaction reagent Substances 0.000 claims description 38
- 238000003786 synthesis reaction Methods 0.000 claims description 36
- 230000015572 biosynthetic process Effects 0.000 claims description 34
- 238000002600 positron emission tomography Methods 0.000 claims description 33
- 239000000700 radioactive tracer Substances 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 21
- 238000004140 cleaning Methods 0.000 claims description 21
- 238000005349 anion exchange Methods 0.000 claims description 18
- 230000008569 process Effects 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000012530 fluid Substances 0.000 claims description 14
- 239000002243 precursor Substances 0.000 claims description 14
- 238000001044 reversed-phase solid-phase extraction Methods 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 238000010511 deprotection reaction Methods 0.000 claims description 12
- 238000000746 purification Methods 0.000 claims description 12
- 239000003480 eluent Substances 0.000 claims description 11
- 239000012071 phase Substances 0.000 claims description 10
- HIIJZYSUEJYLMX-UHFFFAOYSA-N 1-fluoro-3-(2-nitroimidazol-1-yl)propan-2-ol Chemical compound FCC(O)CN1C=CN=C1[N+]([O-])=O HIIJZYSUEJYLMX-UHFFFAOYSA-N 0.000 claims description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 238000004891 communication Methods 0.000 claims description 9
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 8
- 125000002091 cationic group Chemical group 0.000 claims description 8
- KRHYYFGTRYWZRS-BJUDXGSMSA-M fluorine-18(1-) Chemical compound [18F-] KRHYYFGTRYWZRS-BJUDXGSMSA-M 0.000 claims description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 6
- NTEDWGYJNHZKQW-DGMDOPGDSA-N fluciclovine ((18)F) Chemical compound OC(=O)[C@]1(N)C[C@H]([18F])C1 NTEDWGYJNHZKQW-DGMDOPGDSA-N 0.000 claims description 6
- 229940027541 fluciclovine f-18 Drugs 0.000 claims description 6
- 229910052700 potassium Inorganic materials 0.000 claims description 6
- 239000011591 potassium Substances 0.000 claims description 6
- AOYNUTHNTBLRMT-SLPGGIOYSA-N 2-deoxy-2-fluoro-aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](F)C=O AOYNUTHNTBLRMT-SLPGGIOYSA-N 0.000 claims description 5
- 239000002152 aqueous-organic solution Substances 0.000 claims description 5
- -1 quaternary ammonium anions Chemical class 0.000 claims description 5
- 150000005621 tetraalkylammonium salts Chemical class 0.000 claims description 4
- LPZSRGRDVVGMMX-JWXFUTCRSA-N (2s,3s,4s,5s)-2-(fluoromethyl)-5-(2-nitroimidazol-1-yl)oxolane-3,4-diol Chemical compound O1[C@H](CF)[C@@H](O)[C@H](O)[C@H]1N1C([N+]([O-])=O)=NC=C1 LPZSRGRDVVGMMX-JWXFUTCRSA-N 0.000 claims description 3
- UXCAQJAQSWSNPQ-ZIVQXEJRSA-N 1-[(2r,4s,5r)-4-fluoranyl-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H]([18F])C1 UXCAQJAQSWSNPQ-ZIVQXEJRSA-N 0.000 claims description 3
- IKWJWCZWJVPPIC-UHFFFAOYSA-N 2-[(4-fluoro-3-iodophenyl)methyl]guanidine Chemical compound NC(N)=NCC1=CC=C(F)C(I)=C1 IKWJWCZWJVPPIC-UHFFFAOYSA-N 0.000 claims description 3
- 102100030771 Ferrochelatase, mitochondrial Human genes 0.000 claims description 3
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims description 3
- 101000843611 Homo sapiens Ferrochelatase, mitochondrial Proteins 0.000 claims description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 3
- 229910052792 caesium Inorganic materials 0.000 claims description 3
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 claims description 3
- HVTQGIFBNBMSGE-JZRMKITLSA-N fluoroethylcholine (18F) Chemical compound OCC[N+](C)(C)CC[18F] HVTQGIFBNBMSGE-JZRMKITLSA-N 0.000 claims description 3
- 229960002949 fluorouracil Drugs 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 3
- 229910052701 rubidium Inorganic materials 0.000 claims description 3
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 claims description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 2
- 230000002194 synthesizing effect Effects 0.000 claims description 2
- NLMDJJTUQPXZFG-UHFFFAOYSA-N 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane Chemical compound C1COCCOCCNCCOCCOCCN1 NLMDJJTUQPXZFG-UHFFFAOYSA-N 0.000 claims 1
- 150000001450 anions Chemical class 0.000 claims 1
- 239000002739 cryptand Substances 0.000 claims 1
- 238000001311 chemical methods and process Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 239000007790 solid phase Substances 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 230000000717 retained effect Effects 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 125000006239 protecting group Chemical group 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 230000007613 environmental effect Effects 0.000 description 5
- 125000000524 functional group Chemical group 0.000 description 5
- 238000002372 labelling Methods 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000005855 radiation Effects 0.000 description 5
- 239000012217 radiopharmaceutical Substances 0.000 description 5
- 229940121896 radiopharmaceutical Drugs 0.000 description 5
- 230000002799 radiopharmaceutical effect Effects 0.000 description 5
- 230000005526 G1 to G0 transition Effects 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- OIBDVHSTOUGZTJ-PEBLQZBPSA-N [(2r,3r,4s,5s,6s)-3,4,6-triacetyloxy-5-(trifluoromethylsulfonyloxy)oxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@H]1O[C@@H](OC(C)=O)[C@@H](OS(=O)(=O)C(F)(F)F)[C@@H](OC(C)=O)[C@@H]1OC(C)=O OIBDVHSTOUGZTJ-PEBLQZBPSA-N 0.000 description 4
- 238000004817 gas chromatography Methods 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000004255 ion exchange chromatography Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 235000011007 phosphoric acid Nutrition 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-O Methylammonium ion Chemical group [NH3+]C BAVYZALUXZFZLV-UHFFFAOYSA-O 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000003637 basic solution Substances 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000012864 cross contamination Methods 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000003682 fluorination reaction Methods 0.000 description 2
- 150000002222 fluorine compounds Chemical class 0.000 description 2
- 238000011194 good manufacturing practice Methods 0.000 description 2
- 239000012216 imaging agent Substances 0.000 description 2
- 238000011503 in vivo imaging Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000010884 ion-beam technique Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical group [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002594 sorbent Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000010977 unit operation Methods 0.000 description 2
- 239000008215 water for injection Substances 0.000 description 2
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 1
- AUFVJZSDSXXFOI-UHFFFAOYSA-N 2.2.2-cryptand Chemical compound C1COCCOCCN2CCOCCOCCN1CCOCCOCC2 AUFVJZSDSXXFOI-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 238000012879 PET imaging Methods 0.000 description 1
- 229920004738 ULTEM® Polymers 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 230000008275 binding mechanism Effects 0.000 description 1
- 238000010504 bond cleavage reaction Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000012351 deprotecting agent Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229910000027 potassium carbonate Chemical group 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 238000003608 radiolysis reaction Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/005—Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00495—Means for heating or cooling the reaction vessels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00709—Type of synthesis
- B01J2219/00716—Heat activated synthesis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00731—Saccharides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361903486P | 2013-11-13 | 2013-11-13 | |
| US61/903,486 | 2013-11-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BE1022357B1 BE1022357B1 (fr) | 2016-03-24 |
| BE1022357A9 true BE1022357A9 (fr) | 2017-02-02 |
Family
ID=51897262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE20145062A BE1022357A9 (fr) | 2013-11-13 | 2014-11-12 | Cassette à double fonction |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10584078B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3068747B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6496726B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102335535B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN104762666A (cg-RX-API-DMAC7.html) |
| BE (1) | BE1022357A9 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2930479C (cg-RX-API-DMAC7.html) |
| DE (2) | DE202014010612U1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK3068747T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3005832T3 (cg-RX-API-DMAC7.html) |
| FI (1) | FI3068747T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20250050T1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE069777T2 (cg-RX-API-DMAC7.html) |
| IL (1) | IL235650B (cg-RX-API-DMAC7.html) |
| PL (1) | PL3068747T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT3068747T (cg-RX-API-DMAC7.html) |
| RS (1) | RS66442B1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015071288A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201420094D0 (en) * | 2014-11-12 | 2014-12-24 | Ge Healthcare Ltd | Flouride trapping arrangement |
| US10109385B2 (en) | 2009-09-23 | 2018-10-23 | Abt Molecular Imaging, Inc. | Dose synthesis card for use with automated biomarker production system |
| US10584078B2 (en) * | 2013-11-13 | 2020-03-10 | Ge Healthcare Limited | Dual run cassette for the synthesis of 18F-labelled compounds |
| GB201420093D0 (en) | 2014-11-12 | 2014-12-24 | Ge Healthcare Ltd | Pet tracer purification system |
| CN107530455A (zh) * | 2015-02-10 | 2018-01-02 | Abt分子成像公司 | 与自动化生物标记物生产系统联用的剂量合成卡 |
| GB201504287D0 (en) | 2015-03-13 | 2015-04-29 | Ge Healthcare Ltd | Piercing device |
| NL2014828B1 (en) | 2015-05-20 | 2017-01-31 | Out And Out Chemistry S P R L | Method of performing a plurality of synthesis processes of preparing a radiopharmaceutical in series, a device and cassette for performing this method. |
| JP6913968B2 (ja) | 2017-06-19 | 2021-08-04 | フューチャーケム カンパニー リミテッドＦｕｔｕｒｅｃｈｅｍ Ｃｏ．，Ｌｔｄ． | 前立腺がんの診断のための１８ｆ標識化合物およびその使用 |
| WO2018236115A1 (ko) | 2017-06-19 | 2018-12-27 | (주)퓨쳐켐 | 전립선암 진단을 위한 18f-표지된 화합물 및 그의 용도 |
| WO2019058947A1 (ja) * | 2017-09-19 | 2019-03-28 | 株式会社村田製作所 | 濾過装置及び濾過方法 |
| CN111107920A (zh) | 2017-09-25 | 2020-05-05 | 株式会社村田制作所 | 过滤装置 |
| CN108126648A (zh) * | 2018-01-04 | 2018-06-08 | 江苏华益科技有限公司 | 一种放射性药物的自动传输装置及方法 |
| CN113413840A (zh) * | 2021-06-04 | 2021-09-21 | 四川玖谊源粒子科技有限公司 | 一种用于制备多核素放射性药物的合成系统 |
| BE1032491B1 (fr) | 2024-03-27 | 2025-10-27 | Trasis S A | Synthèse de traceurs à plusieurs passages sur cassette |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5082980A (en) * | 1990-06-13 | 1992-01-21 | Case Western Reserve University | Process and apparatus for synthesizing oxygen-15 labelled butanol for positron emission tomography |
| US7413714B1 (en) | 2000-07-16 | 2008-08-19 | Ymc Co. Ltd. | Sequential reaction system |
| CN100374453C (zh) * | 2005-11-18 | 2008-03-12 | 南方医科大学南方医院 | 2－18f－2－脱氧－d－葡萄糖的合成工艺 |
| WO2007063940A1 (ja) * | 2005-12-02 | 2007-06-07 | Nihon Medi-Physics Co., Ltd. | 放射性フッ素標識化合物の製造方法 |
| JP4926546B2 (ja) | 2006-05-30 | 2012-05-09 | 住友重機械工業株式会社 | 放射性薬液合成装置の使用方法、及び放射性薬液合成装置 |
| KR20110106895A (ko) * | 2008-12-22 | 2011-09-29 | 바이엘 파마 악티엔게젤샤프트 | 교환 수지를 사용하여 방사성핵종-표지된 화합물을 합성하는 방법 |
| CN101830937B (zh) * | 2009-03-12 | 2012-06-06 | 张锦明 | 可视化、双反应管氟-18多功能自动化合成模块 |
| JP2012532164A (ja) * | 2009-07-10 | 2012-12-13 | バイエル ファーマ アクチエンゲゼルシャフト | 放射性トレーサーの精製のための低‐中圧液体クロマトグラフィーの使用 |
| US10639608B2 (en) * | 2010-04-08 | 2020-05-05 | Siemens Medical Solutions Usa, Inc. | System, device and method for preparing tracers and transferring materials during radiosynthesis |
| DE102010036356A1 (de) | 2010-07-12 | 2012-01-12 | Abx Advanced Biochemical Compounds Gmbh | Vorrichtung zur Synthese radioaktiv markierter Verbindungen |
| US20120108858A1 (en) * | 2010-10-28 | 2012-05-03 | Maxim Kiselev | Method and device for manufacturing of radiopharmaceuticals |
| US11504430B2 (en) | 2010-12-29 | 2022-11-22 | Ge Healthcare Limited | Eluent solution |
| US20130060017A1 (en) | 2011-07-15 | 2013-03-07 | Cardinal Health 414, Llc | Methods for synthesizing labeled compounds |
| GB201117785D0 (en) | 2011-10-14 | 2011-11-30 | Ge Healthcare Ltd | Improved radiosynthesis method |
| GB201117786D0 (en) | 2011-10-14 | 2011-11-30 | Ge Healthcare Ltd | Eluent vial |
| GB201120586D0 (en) * | 2011-11-30 | 2012-01-11 | Ge Healthcare Ltd | Solid phase extraction neutralisation |
| US10584078B2 (en) * | 2013-11-13 | 2020-03-10 | Ge Healthcare Limited | Dual run cassette for the synthesis of 18F-labelled compounds |
-
2014
- 2014-11-12 US US15/033,321 patent/US10584078B2/en active Active
- 2014-11-12 HR HRP20250050TT patent/HRP20250050T1/hr unknown
- 2014-11-12 PT PT147967624T patent/PT3068747T/pt unknown
- 2014-11-12 KR KR1020167012207A patent/KR102335535B1/ko active Active
- 2014-11-12 FI FIEP14796762.4T patent/FI3068747T3/fi active
- 2014-11-12 WO PCT/EP2014/074330 patent/WO2015071288A1/en not_active Ceased
- 2014-11-12 CA CA2930479A patent/CA2930479C/en active Active
- 2014-11-12 ES ES14796762T patent/ES3005832T3/es active Active
- 2014-11-12 RS RS20250079A patent/RS66442B1/sr unknown
- 2014-11-12 PL PL14796762.4T patent/PL3068747T3/pl unknown
- 2014-11-12 HU HUE14796762A patent/HUE069777T2/hu unknown
- 2014-11-12 BE BE20145062A patent/BE1022357A9/fr active
- 2014-11-12 JP JP2016528871A patent/JP6496726B2/ja active Active
- 2014-11-12 EP EP14796762.4A patent/EP3068747B1/en active Active
- 2014-11-12 CN CN201410858370.9A patent/CN104762666A/zh active Pending
- 2014-11-12 DK DK14796762.4T patent/DK3068747T3/da active
- 2014-11-12 IL IL23565014A patent/IL235650B/en active IP Right Grant
- 2014-11-12 CN CN202110731994.4A patent/CN113564722A/zh active Pending
- 2014-11-12 DE DE202014010612.6U patent/DE202014010612U1/de not_active Expired - Lifetime
-
2015
- 2015-05-26 DE DE202015007501.0U patent/DE202015007501U1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IL235650A0 (en) | 2015-02-26 |
| FI3068747T3 (fi) | 2024-12-30 |
| WO2015071288A1 (en) | 2015-05-21 |
| JP2017503752A (ja) | 2017-02-02 |
| DK3068747T3 (da) | 2025-01-13 |
| DE202015007501U1 (de) | 2015-12-17 |
| EP3068747A1 (en) | 2016-09-21 |
| US20160257622A1 (en) | 2016-09-08 |
| BE1022357B1 (fr) | 2016-03-24 |
| DE202014010612U1 (de) | 2016-04-19 |
| JP6496726B2 (ja) | 2019-04-03 |
| KR102335535B1 (ko) | 2021-12-08 |
| PT3068747T (pt) | 2025-01-24 |
| HRP20250050T1 (hr) | 2025-04-11 |
| CA2930479C (en) | 2023-03-28 |
| EP3068747B1 (en) | 2024-10-30 |
| KR20160085769A (ko) | 2016-07-18 |
| US10584078B2 (en) | 2020-03-10 |
| CN113564722A (zh) | 2021-10-29 |
| CA2930479A1 (en) | 2015-05-21 |
| IL235650B (en) | 2019-10-31 |
| ES3005832T3 (en) | 2025-03-17 |
| CN104762666A (zh) | 2015-07-08 |
| HUE069777T2 (hu) | 2025-04-28 |
| PL3068747T3 (pl) | 2025-03-10 |
| RS66442B1 (sr) | 2025-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE1022357A9 (fr) | Cassette à double fonction | |
| CN103958049B (zh) | 包括水解去保护步骤和固相萃取的18f‑标记化合物的纯化 | |
| JP6574379B2 (ja) | １８ｆ−フルシクロビンの製造 | |
| JP6737782B2 (ja) | フッ化物を捕捉する配置 | |
| BE1023528A1 (fr) | Procédé pour effectuer un certain nombre de procédés de synthèse de la préparation d'un composé pharmaceutique radiomarqué en série, un dispositif et une cassette pour la mise en oeuvre de ce procédé | |
| JP6726665B2 (ja) | Ｐｅｔトレーサー精製システム | |
| BE1032491B1 (fr) | Synthèse de traceurs à plusieurs passages sur cassette | |
| JP7467353B2 (ja) | 固相抽出 | |
| US20250051245A1 (en) | Method for the preparation of a composition comprising dissolved [18f]fluoride and composition obtainable by the method | |
| EP4529536A1 (en) | Cgmp-compliant automated [18f]fspg production for clinical examination |